Factors Affecting Influenza Vaccine Uptake
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Influenza Virus Vaccines".
Deadline for manuscript submissions: 20 October 2025 | Viewed by 932
Special Issue Editor
Interests: vaccination hesitancy; influenza epidemiology; other viral respiratory infections
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Influenza symptoms can range from mild to severe. Seasonal epidemics and sporadic pandemics typically characterize influenza. The influenza vaccine helps protect against influenza illness, which can be serious or life-threatening. Routine annual influenza vaccination is recommended for all persons aged ≥ 6 months who do not have contraindications. Frequently reported barriers to vaccination include concerns regarding vaccine safety or efficacy, vaccine hesitancy, lack of insurance, cost of vaccination, perceived lack of risk, and lack of guidelines or education.
Original research articles and reviews are welcome for this Special Issue. Research areas may include (but are not limited to) the following: factors affecting influenza vaccination rates in the general population and high-risk groups, methods to evaluate influenza vaccine uptake and reduce hesitancy, and hesitancy determinants.
I look forward to receiving your contributions.
Prof. Dr. Adriana Pistol
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- influenza
- vaccines
- coverage
- uptake
- hesitancy
- risk groups
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
